Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128a1 · Date: 20260120 · State: NJ
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
3,886
Total Claims
$343K
Drug Cost
593
Beneficiaries
$578
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-51%
Cost per patient vs peers
$578 vs $1,174 avg
+22%
Brand preference vs peers
10.9% vs 8.9% avg
Brand vs Generic
Brand: 417 claims · $279K
Generic: 3,424 claims · $63K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lipase/Protease/Amylase | 21 | $42K |
| Icosapent Ethyl | 44 | $40K |
| Empagliflozin | 17 | $29K |
| Sitagliptin Phosphate | 15 | $19K |
| Linagliptin | 12 | $19K |
| Linaclotide | 25 | $19K |
| Apixaban | 17 | $18K |
| Diclofenac Sodium | 212 | $6,002 |
| Albuterol Sulfate | 92 | $3,481 |
| Triamcinolone Acetonide | 103 | $2,437 |
| Tobramycin/Dexamethasone | 41 | $2,377 |
| Atorvastatin Calcium | 142 | $2,160 |
| Rosuvastatin Calcium | 39 | $1,682 |
| Losartan Potassium | 88 | $1,395 |
| Metoprolol Succinate | 75 | $1,356 |
Prescribing Profile
Patient Profile
74
Avg Age
57%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About